<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38597540</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>2</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>Sudden Death in a Breastfeeding Woman with Arrhythmogenic Mitral Valve Prolapse.</ArticleTitle><Pagination><StartPage>e20230358</StartPage><MedlinePgn>e20230358</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20230358</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20230358</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2024000200502</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bragan&#xe7;a</LastName><ForeName>Erika Olivier Vilela</ForeName><Initials>EOV</Initials><Identifier Source="ORCID">0000-0002-9168-5513</Identifier><AffiliationInfo><Affiliation>RitmoCheck, S&#xe3;o Jos&#xe9; dos Campos, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Fabio Luis Val&#xe9;rio da</ForeName><Initials>FLVD</Initials><AffiliationInfo><Affiliation>RitmoCheck, S&#xe3;o Jos&#xe9; dos Campos, SP - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>Morte S&#xfa;bita em Lactante Portadora de Prolapso da V&#xe1;lvula Mitral Arritmog&#xea;nico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001942" MajorTopicYN="N">Breast Feeding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="N">Death, Sudden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="N">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Potencial conflito de interesse. N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>8</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38597540</ArticleId><ArticleId IdType="pmc">PMC12092033</ArticleId><ArticleId IdType="doi">10.36660/abc.20230358</ArticleId><ArticleId IdType="pii">S0066-782X2024000200502</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, et al. Prevalence and Clinical Outcome of Mitral-Valve Prolapse. N Engl J Med . 1999;341(1):1&#x2013;7. doi: 10.1056/NEJM199907013410101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199907013410101</ArticleId><ArticleId IdType="pubmed">10387935</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Marra MP, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation . 2015;132(7):556&#x2013;566. doi: 10.1161/CIRCULATIONAHA.115.016291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.016291</ArticleId><ArticleId IdType="pubmed">26160859</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B, et al. EHRA Expert Consensus Statement on Arrhythmic Mitral Valve Prolapse and Mitral Annular Disjunction Complex in Collaboration with the ESC Council on Valvular Heart Disease and the European Association of Cardiovascular Imaging Endorsed Cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace . 2022;24(12):1981&#x2013;2003. doi: 10.1093/europace/euac125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euac125</ArticleId><ArticleId IdType="pmc">PMC11636573</ArticleId><ArticleId IdType="pubmed">35951656</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld K, Tfelt-Hansen J, Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Eur Heart J . 2022;43(40):3997&#x2013;4126. doi: 10.1093/eurheartj/ehac262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac262</ArticleId><ArticleId IdType="pubmed">36017572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35414724</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>Evaluation of inflammation markers in mitral valve prolapse.</ArticleTitle><Pagination><StartPage>181</StartPage><EndPage>188</EndPage><MedlinePgn>181-188</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.21000127</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Mitral valve prolapse (MVP) is the most common cause of mitral regurgitation in developed countries. The role of inflammation in the pathogenesis of MVP is still not clear. In this study, we aimed to investigate how inflammatory markers such as monocyte/high-density lipoprotein ratio (MHR), lymphocyte/monocyte ratio (LMR), neutrophil/lymphocyte ratio (NLR), and platelet/neutrophil ratio (PLR) are affected in MVP patients.</AbstractText><AbstractText Label="METHODS">In this retrospective study, we included 461 patients with MVP and 459 normal echocardiographic patients, matched with gender and age. Inflammatory markers and all variables were compared between the two groups.</AbstractText><AbstractText Label="RESULTS">There were no statistically significant differences in age, sex, or body mass index between the two groups. Neutrophil counts (4,960 [3,900-6,780]. 4,200 [3,800-5,600], p &lt; 0.001), NLR (2.488 [1.72-4.51], 1.857 [1.49-2.38], p &lt; 0.001), MHR (14.9 [11.9-18.6], 12.2 [9.4-17.3], p = 0.003), PLR (122.4 [85-171], 104.4 [85-130], p &lt; 0.001), and CRP (0.71 &#xb1; 0.50, 0.67 &#xb1; 0.33 p &lt; 0.001) were significantly higher, and LMR (3.75 [2.75-5.09], 4.06 [3.12-4.83] p = 0.016) was significantly lower in the MVP group than the control group, respectively. In logistic regression analysis, NLR (odds ratio [OR]: 1.058 [1.047-1.072]; p &lt; 0.001), LMR (OR: 1.560 [1.211-2.522]; p = 0.027), and PLR (OR: 1.015 [1.012-1.019]; p = 0.003) were found to be independent predictors for MVP presence.</AbstractText><AbstractText Label="CONCLUSIONS">These parameters can be used as a simple, low-cost, practical tool to detect inflammation in MVP.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yalim</LastName><ForeName>Zafer</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ersoy</LastName><ForeName>&#x130;brahim</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Evaluaci&#xf3;n de los marcadores de inflamaci&#xf3;n en el prolapso de la v&#xe1;lvula mitral.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO">El prolapso de la v&#xe1;lvula mitral (MVP) es la causa m&#xe1;s com&#xfa;n de insuficiencia mitral en los pa&#xed;ses desarrollados. El papel de la inflamaci&#xf3;n en la patogenia del MVP a&#xfa;n no est&#xe1; claro. En este estudio, nuestro objetivo fue investigar c&#xf3;mo los marcadores inflamatorios como la proporci&#xf3;n monocitos/HDL (MHR), la proporci&#xf3;n linfocitos/monocitos (LMR), la proporci&#xf3;n neutr&#xf3;filos/linfocitos (NLR) y la proporci&#xf3;n plaquetas/neutr&#xf3;filos (PLR) se ven afectados en pacientes con MVP.</AbstractText><AbstractText Label="M&#xc9;TODOS">En este estudio retrospectivo, incluimos a 461 pacientes con PVM y 459 pacientes ecocardiogr&#xe1;ficos normales, emparejados por sexo y edad. Se compararon los marcadores inflamatorios y todas las variables entre los dos grupos.</AbstractText><AbstractText Label="RESULTADOS">No hubo diferencias estad&#xed;sticamente significativas en edad, sexo o &#xed;ndice de masa corporal entre los dos grupos. El recuento de neutr&#xf3;filos (4,960 [3,900-6,780], 4,200 [3,800-5,600], p &lt; 0.001), NLR (2.488 [1.72-4.51], 1,857 [1.49-2.38], p &lt; 0.001), MHR (14.9 [11.9-18.6]), (12.2 [9.4-17.3], p = 0.003), PLR (122.4 [85-171], 104.4 [85-130], p &lt; 0.001) y PCR (0.71 &#xb1; 0.50, 0.67 &#xb1; 0.33 p &lt; 0.001) fueron significativamente mayores y LMR (3.75 [2.75-5.09], 4.06 [3.12-4.83] p = 0.016) fue significativamente menor en el grupo MVP que en el grupo de control, respectivamente. En el an&#xe1;lisis de regresi&#xf3;n log&#xed;stica; NLR (OR: 1.058 [1.047-1.072]; p &lt; 0.001), LMR (OR: 1.560 [1.211-2.522]; p = 0.027) y PLR (OR: 1.015 [1.012-1.019]; p = 0.003) se encontraron como predictores independientes para la presencia de MVP.</AbstractText><AbstractText Label="CONCLUSIONES">Estos par&#xe1;metros pueden utilizarse como una herramienta sencilla, pr&#xe1;ctica y de bajo costo para detectar la inflamaci&#xf3;n en el PVM.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Permanyer.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarcadores</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Inflamaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">Neutrophil-to-lymphocyte ratio</Keyword><Keyword MajorTopicYN="N">Platelet-to-neutrophil ratio</Keyword><Keyword MajorTopicYN="N">Prolapso de la v&#xe1;lvula mitral</Keyword><Keyword MajorTopicYN="N">Proporci&#xf3;n de neutr&#xf3;filos a linfocitos</Keyword><Keyword MajorTopicYN="N">Proporci&#xf3;n de plaquetas a neutr&#xf3;filos</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35414724</ArticleId><ArticleId IdType="pmc">PMC9005184</ArticleId><ArticleId IdType="doi">10.24875/ACM.21000127</ArticleId><ArticleId IdType="pii">j92/2/181</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parwani P, Avierinos JF, Levine RA, Delling FN. Mitral valve prolapse:multimodality imaging and genetic insights. Prog Cardiovasc Dis. 2017;60:361&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805573</ArticleId><ArticleId IdType="pubmed">29122631</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population:the benign nature of echocardiographic features in the Framingham heart study. J Am Coll Cardiol. 2002;40:1298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">12383578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to. J Am Coll Cardiol. 2008;52:e1&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">18848134</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereux RB, Kramer-Fox R, Shear MK, Kligfield P, Pini R, Savage DD. Diagnosis and classification of severity of mitral valve prolapse:methodologic, biologic, and prognostic considerations. Am Heart J. 1987;113:1265&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">3554945</ArticleId></ArticleIdList></Reference><Reference><Citation>Luxereau P, Dorent R, De Gevigney G, Bruneaval P, Chomette G, Delahaye G. Aetiology of surgically treated mitral regurgitation. Eur Heart J. 1991;12:2&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1936017</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RA, Hag&#xe9;ge AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, et al. Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol. 2015;12:689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4804623</ArticleId><ArticleId IdType="pubmed">26483167</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rsoy OM, Karakoyun S, Kal&#xe7;&#x131;k M, G&#xf6;kdeniz T, Yesin M, G&#xfc;nd&#xfc;z S, et al. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol. 2014;113:860&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24411287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18773982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya H, Erta&#x15f; F, &#x130;slamo&#x11f;lu Y, Kaya Z, At&#x131;lgan ZA, &#xc7;il H, et al. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb. 2014;20:50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">22790659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin MS, Cetin EH, Kalender E, Aydin S, Topaloglu S, Kisacik HL, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Hear Lung Circ. 2016;25:1077&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">27118231</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir V, Samet Y, Akboga MK. Association of lymphocyte-monocyte ratio and monocyte-to-high-density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis. Biomark Med. 2017;11:657&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28770612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yayla &#xc7;, Akboga MK, Canpolat U, Gayretli Yayla K, Kuyumcu MS, Bayraktar F, et al. The association of the platelet-to-lymphocyte ratio with mitral annular calcification. Scand Cardiovasc J. 2015;49:351&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26287644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamukcu HE, Aker M. Association between monocyte to HDL cholesterol ratio and mitral annulus calcification. J Surg Med. 2019;3:44&#x2013;8.</Citation></Reference><Reference><Citation>Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse:new insights into disease progression, genetics, and molecular basis. Circulation. 2014;129:2158&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052751</ArticleId><ArticleId IdType="pubmed">24867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15705461</ArticleId></ArticleIdList></Reference><Reference><Citation>Flack JM, Kvasnicka JH, Gardin JM, Gidding SS, Manolio TA, Jacobs DR, Jr, et al. Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults:the CARDIA study. Am Heart J. 1999;138:486&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">10467199</ArticleId></ArticleIdList></Reference><Reference><Citation>Avierinos JF, Gersh BJ, Melton Iii LJ, Bailey KR, Shub C, Nishimura RA, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106:1355&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221052</ArticleId></ArticleIdList></Reference><Reference><Citation>Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease:atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8:222.</Citation><ArticleIdList><ArticleId IdType="pubmed">21304474</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 2009;16:667&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">19199930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang FJ, Yuan HY, Hu XX, Ou ZJ, Fu L, Lin ZB, et al. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase. J Mol Cell Cardiol. 2014;74:209&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">24887036</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber Y, Goldbourt U, Feinberg MS, Segev S, Harats D. Are triglyceride-rich lipoproteins associated with aortic valve sclerosis?:a preliminary report. Atherosclerosis. 2003;170:301&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14612211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghani M, Burwash IG, Chan KL. Cholesterol and triglyceride levels in congenital bicuspid aortic valve:risk factors for aortic stenosis. Circulation. 1998;98:699.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Edep ME, Shirani J, Wolf P, Brown DL. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol. 2000;9:281&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11064275</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo S, Basso C, Lazzarini E, Celeghin R, Paolin A, Gerosa G, et al. TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse. Cardiovasc Pathol. 2015;24:359&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">26345253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulin A, Anstine LJ, Kim AJ, Potter SJ, DeFalco T, Lincoln J, et al. Macrophage transitions in heart valve development and myxomatous valve disease. Arterioscler Thromb Vasc Biol. 2018;38:636&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823761</ArticleId><ArticleId IdType="pubmed">29348122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse HF, Lau CP, Cheng G. Relation between mitral regurgitation and platelet activation. J Am Coll Cardiol. 1997;30:1813&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385912</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, Denaxas S, Nicholas O, Hingorani AD, Hemingway H. Neutrophil counts and initial presentation of 12 cardiovascular diseases:a CALIBER cohort study. J Am Coll Cardiol. 2017;69:1160&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5332591</ArticleId><ArticleId IdType="pubmed">28254179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">20102916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ethier JL, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer:a systematic review and meta-analysis. Breast Cancer Res. 2017;19:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5217326</ArticleId><ArticleId IdType="pubmed">28057046</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcea C, Buzea CA, Dan GA. The neutrophil to lymphocyte ratio in heart failure:a comprehensive review. Rom J Intern Med. 2019;57:296&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">31301680</ArticleId></ArticleIdList></Reference><Reference><Citation>Balta S, Demirkol S, Unlu M, Arslan Z, Celik T. Neutrophil to lymphocyte ratio may be predict of mortality in all conditions. Br J Cancer. 2013;109:3125&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859933</ArticleId><ArticleId IdType="pubmed">24084765</ArticleId></ArticleIdList></Reference><Reference><Citation>Polat N, Yildiz A, Yuksel M, Bilik MZ, Aydin M, Acet H, et al. Association of neutrophil-lymphocyte ratio with the presence and severity of rheumatic mitral valve stenosis. Clin Appl Thromb. 2014;20:793&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24335245</ArticleId></ArticleIdList></Reference><Reference><Citation>Abacioglu OO. Monocyte to high-density lipoprotein ratio:a prognostic factor for mitral valve prolapse? Bratisl Lek Listy. 2020;121:151&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32115969</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xfc;ksel M, Y&#x131;ld&#x131;z A, Oylumlu M, Aky&#xfc;z A, Ayd&#x131;n M, Kaya H, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2016;15:640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5336865</ArticleId><ArticleId IdType="pubmed">25550173</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh PN, Kansu TA, Corbett JJ, Savion PJ, Goldburgh WP, Schatz NJ. Platelets, thromboembolism and mitral valve prolapse. Circulation. 1981;63:552&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7460240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46:1619&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">24853998</ArticleId></ArticleIdList></Reference><Reference><Citation>Selcuk M, Yildirim E, Saylik F. Comparison of monocyte with high density lipoprotein cholesterol ratio in dipper and nondipper hypertensive patients. Biomark Med. 2019;13:1289&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">31596122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33232309</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>[The mitral annulus disjunction as a risk marker in mitral valve prolapse].</ArticleTitle><Pagination><StartPage>347</StartPage><EndPage>354</EndPage><MedlinePgn>347-354</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.200003661</ELocationID><Abstract><AbstractText>Disjunction of the mitral valve annulus is a structural abnormality consisting of an atrial displacement of the articulation point of the mitral valve, leading to an altered spatial relationship between the valve and the adjacent posterior ventricular wall. Studies have shown the relationship between mitral annular disjunction, ventricular arrhythmias, and myocardial fibrous degeneration, which increases the risk of sudden death, especially among young women. The case of a 30-year-old woman with no relevant pathological history with frequent palpitations is presented, in whom an increase in ventricular automatism with a progressive increase in the arrhythmic load of up to 20% with a weight of pharmacological management is documented. In a cardiac magnetic resonance, a 15 mm displacement towards the atrium of the mitral leaflets compatible with mitral annular disjunction and late enhancement foci of mesocardial, non-coronary distribution were observed. Given the findings and the persistence of symptoms, an electrophysiological study, 3D mapping, and ablation were performed. Two hyperechoic regions were seen on intracardiac ultrasound, one in the length of the anterior papillary muscle and the other in the mesocardium of the base of the posterior papillary muscle. Both foci related to the morphological sites of interest in which radiofrequency energy was applied. During the procedure presented an episode of ventricular fibrillation. A malignant ventricular extrasystole was considered and therefore a cardio defibrillator was implanted for the secondary prevention of sudden death. The literature was reviewed and the specific pathophysiological relationships between mitral annular disjunction, premature ventricular complexes, and risk of sudden death were analyzed. The role of electrophysiological study and ablation in symptomatic patients refractory to pharmacological treatment is described.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hern&#xe1;ndez</LastName><ForeName>Keerby</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Departamento de Cardiolog&#xed;a Pedi&#xe1;trica, Universidad Pontificia Bolivariana, Cl&#xed;nica CardioVID, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agudelo-Uribe</LastName><ForeName>Juan F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Servicio de Electrofisiolog&#xed;a, Cl&#xed;nica CardioVID, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Barrea</LastName><ForeName>Juan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Servicio de Electrofisiolog&#xed;a, Cl&#xed;nica CardioVID, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abad-D&#xed;az</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Imagen Cardiovascular, SURA. Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correa-Vel&#xe1;squez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Electrofisiolog&#xed;a, Cl&#xed;nica CardioVID, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;enz-Jaramillo</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Electrofisiolog&#xed;a, Cl&#xed;nica CardioVID, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Disyunci&#xf3;n del anillo mitral como marcador de riesgo en prolapso de v&#xe1;lvula mitral.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La disyunci&#xf3;n del anillo valvular mitral es una anormalidad estructural que consiste en un desplazamiento auricular del punto de articulaci&#xf3;n de la v&#xe1;lvula mitral, lo que lleva a una relaci&#xf3;n espacial alterada entre la v&#xe1;lvula y la pared ventricular posterior adyacente. Los estudios han demostrado una relaci&#xf3;n entre la disyunci&#xf3;n del anillo mitral, las arritmias ventriculares y la degeneraci&#xf3;n fibrosa mioc&#xe1;rdica, lo que incrementa el riesgo de muerte s&#xfa;bita, en especial en mujeres j&#xf3;venes. Se presenta el caso de una mujer de 30 a&#xf1;os, sin antecedentes relevantes, con palpitaciones frecuentes, en quien se document&#xf3; un aumento del automatismo ventricular con incremento progresivo de la carga arr&#xed;tmica hasta el 20% a pesar del manejo farmacol&#xf3;gico. En la resonancia cardiaca se apreci&#xf3; un desplazamiento de 15 mm hacia la aur&#xed;cula de las valvas de la mitral compatible con disyunci&#xf3;n del anillo mitral, adem&#xe1;s de focos de realce tard&#xed;o de distribuci&#xf3;n mesoc&#xe1;rdica, no coronariana. Ante los hallazgos y la persistencia de los s&#xed;ntomas, se llev&#xf3; a estudio electrofisiol&#xf3;gico, mapeo 3D y ablaci&#xf3;n. En la ecograf&#xed;a intracardiaca se apreciaron dos regiones hiperecoicas, en la longitud del m&#xfa;sculo papilar anterior y en el mesocardio de la base del m&#xfa;sculo papilar posterior; ambos focos relacionados con los sitios morfol&#xf3;gicos de inter&#xe9;s, en los cuales se aplic&#xf3; energ&#xed;a de radiofrecuencia. Durante el procedimiento present&#xf3; un episodio de fibrilaci&#xf3;n ventricular que se consider&#xf3; una extrasistolia ventricular maligna, por lo que se implant&#xf3; un cardiodesfibrilador para prevenci&#xf3;n de muerte s&#xfa;bita. Se revisa la literatura y se analizan las relaciones fisiopatol&#xf3;gicas existentes entre la disyunci&#xf3;n del anillo mitral, los complejos ventriculares prematuros y el riesgo de muerte s&#xfa;bita.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Ventricular fibrillation</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">Mitral valve</Keyword></KeywordList><CoiStatement>Los autores declaran que no tienen ning&#xfa;n conflicto de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33232309</ArticleId><ArticleId IdType="pmc">PMC8351651</ArticleId><ArticleId IdType="doi">10.24875/ACM.200003661</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bharati S, Granston AS, Liebson PR, Loeb HS, Rosen KM, Lev M. The conduction system in mitral valve prolapse syndrome with sudden death. Am Heart J. 1981;101:667&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">7223606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. N Engl J Med. 1986;314:535&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">3945291</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson MJ, Bitkover CY, Omran AS, David TE, Ivanov J, Ali MJ, et al. Mitral annular disjunction in advanced myxomatous mitral valve disease:echocardiographic detection and surgical correction. J Am Soc Echocardiogr. 2005;18:1014&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert BW, Schatz RA, VonRamm OT, Behar VS, Kisslo JA. Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation. Circulation. 1976;54:716&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">975465</ArticleId></ArticleIdList></Reference><Reference><Citation>Noseworthy PA, Asirvatham SJ. The knot that binds mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:551&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26160860</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya VR, DeSimone CV, Damle N, Naksuk N, Syed FF, Ackerman MJ, et al. Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse. J Interv Card Electrophysiol. 2016;46:137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4925199</ArticleId><ArticleId IdType="pubmed">26768434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">23563135</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukumar L, Jahangir A, Jan MF, Perez Moreno AC, Khandheria BK, Tajik AJ. Association between malignant mitral valve prolapse and sudden cardiac death:a review. JAMA Cardiol. 2020;5:1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">32936277</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini A, Ho SY, Anderson RH, Davies MJ, Becker AE. A histological study of the atrioventricular junction in hearts with normal and prolapsed leaflets of the mitral valve. Br Heart J. 1988;59:712&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1276881</ArticleId><ArticleId IdType="pubmed">3395530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho SY. Anatomy of the mitral valve. Heart. 2002;88(Suppl 4):iv5&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1876279</ArticleId><ArticleId IdType="pubmed">12369589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F, Chen Y, Huang L, Ren W, Yu X, Ni C. Rare congenital mitral valve malformations assessed by real-time three-dimensional echocardiography. Int J Cardiol. 2016;222:1027&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27533917</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalliah CJ, Mahajan R, Elliott AD, Haqqani H, Lau DH, Vohra JK, et al. Mitral valve prolapse and sudden cardiac death:a systematic review and meta-analysis. Heart. 2019;105:144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30242141</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Forno B, Castiglioni A, Sala A, Geretto A, Giacomini A, Denti P, et al. Mitral valve annuloplasty. Multimed Man Cardiothorac Surg. 2017;2017</Citation><ArticleIdList><ArticleId IdType="pubmed">29300071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Thamman R, Griffiths T, Oxley C, Khan JN, Phan T, et al. Mitral annular disjunction:a systematic review of the literature. Echocardiography. 2019;36:1549&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">31385360</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. Mitral annular disjunction in myxomatous mitral valve disease:a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound. 2010;8:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014886</ArticleId><ArticleId IdType="pubmed">21143934</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AP, Jin CN, Fan Y, Wong RHL, Underwood MJ, Wan S. Functional implication of mitral annular disjunction in mitral valve prolapse:a quantitative dynamic 3D echocardiographic study. JACC Cardiovasc Imaging. 2017;10:1424&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528161</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazzolo Marra M, Basso C. Mechanical dispersion and arrhythmic mitral valve prolapse:substrate and trigger in electrical instability. Heart. 2019;105:1053&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">30971404</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulton BL, Liang JJ, Enriquez A, Garcia FC, Supple GE, Riley MP, et al. Imaging characteristics of papillary muscle site of origin of ventricular arrhythmias in patients with mitral valve prolapse. J Cardiovasc Electrophysiol. 2018;29:146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29059484</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Thamman R, Griffiths T, Oxley C, Khan JN, Phan T, et al. Mitral annular disjunction:a systematic review of the literature. Echocardiography. 2019;36:1549&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">31385360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. Normative reference values for the tissue Doppler imaging parameters of left ventricular function:a population-based study. Eur J Echocardiogr. 2010;11:51&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19910319</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejgaard LA, Skj&#xf8;lsvik ET, Lie &#xd8;, Ribe M, Stokke MK, Hegbom F, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72:1600&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30261961</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26160859</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilde AA, D&#xfc;ren DR, Hauer RN, deBakker JM, Bakker PF, Becker AE, et al. Mitral valve prolapse and ventricular arrhythmias:observations in a patient with a 20-year history. J Cardiovasc Electrophysiol. 1997;8:307&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">9083880</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra J, Sathe S, Warren R, Tatoulis J, Hunt D. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation. Pacing Clin Electrophysiol. 1993;16(3 Pt 1):387&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">7681188</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed FF, Ackerman MJ, McLeod CJ, Kapa S, Mulpuru SK, Sriram CS, et al. Sites of successful ventricular fibrillation ablation in bileaflet mitral valve prolapse syndrome. Circ Arrhythm Electrophysiol. 2016;9:e004005.</Citation><ArticleIdList><ArticleId IdType="pubmed">27103091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Madhavan M, Viqar-Syed M, Asirvatham SJ. Successful ablation of a narrow complex tachycardia arising from a left ventricular false tendon:mapping and optimizing energy delivery. Heart Rhythm. 2014;11:321&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24216521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hai JJ, Desimone CV, Vaidya VR, Asirvatham SJ. Endocavitary structures in the outflow tract:anatomy and electrophysiology of the conus papillary muscles. J Cardiovasc Electrophysiol. 2014;25:94&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4440798</ArticleId><ArticleId IdType="pubmed">24102678</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed FF, Ackerman MJ, McLeod CJ, Kapa S, Mulpuru SK, Sriram CS, et al. Sites of successful ventricular Ffibrillation ablation in Bileaflet mitral valve prolapse syndrome. Circ Arrhythm Electrophysiol. 2016 May;9(5):e004005.</Citation><ArticleIdList><ArticleId IdType="pubmed">27103091</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herendael H, Zado ES, Haqqani H, Tschabrunn CM, Callans DJ, Frankel DS, et al. Catheter ablation of ventricular fibrillation:importance of left ventricular outflow tract and papillary muscle triggers. Heart Rhythm. 2014;11:566&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">24398086</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda T, Shimizu W, Taguchi A, Aiba T, Satomi K, Suyama K, et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol. 2005;46:1288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198845</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheirlynck E, Dejgaard LA, Skj&#xf8;lsvik E, Lie OH, Motoc A, Hopp E, et al. Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias. Open Heart. 2019;6:e001016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519435</ArticleId><ArticleId IdType="pubmed">31168386</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbadi DR, Purbey R, Poornima IG. Mitral valve repair is an effective treatment for ventricular arrhythmias in mitral valve prolapse syndrome. Int J Cardiol. 2014;177:e16&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25149408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocock WA, Barlow JB, Marcus RH, Barlow CW. Mitral valvuloplasty for life-threatening ventricular arrhythmias in mitral valve prolapse. Am Heart J. 1991;121(1 Pt 1):199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">1985363</ArticleId></ArticleIdList></Reference><Reference><Citation>Naksuk N, Syed FF, Krittanawong C, Anderson MJ, Ebrille E, DeSimone CV, et al. The effect of mitral valve surgery on ventricular arrhythmia in patients with bileaflet mitral valve prolapse. Indian Pacing Electrophysiol J. 2016;16:187&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219837</ArticleId><ArticleId IdType="pubmed">28401865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9244950</PMID><DateCompleted><Year>1997</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0034-9356</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>1997</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim</ISOAbbreviation></Journal><ArticleTitle>[Cesarean and prolapse of the mitral valve].</ArticleTitle><Pagination><StartPage>165</StartPage><EndPage>166</EndPage><MedlinePgn>165-6</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de la Cruz</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Ces&#xe1;rea y prolapso de la v&#xe1;lvula mitral.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim</MedlineTA><NlmUniqueID>0134516</NlmUniqueID><ISSNLinking>0034-9356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Rev Esp Anestesiol Reanim. 1996 Oct;43(8):291-3.</RefSource><PMID Version="1">9011900</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000773" MajorTopicYN="N">Anesthesia, Obstetrical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="N">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9244950</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9229736</PMID><DateCompleted><Year>1997</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0034-9356</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>3</Issue><PubDate><Year>1997</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim</ISOAbbreviation></Journal><ArticleTitle>[Anesthesia for cesarean section in patients with mitral valve prolapse].</ArticleTitle><Pagination><StartPage>128</StartPage><EndPage>129</EndPage><MedlinePgn>128-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Romero</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Romero</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gil-Fern&#xe1;ndez</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>Comentarios sobre la anestesia para ces&#xe1;rea en pacientes con prolapso de la v&#xe1;lvula mitral.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim</MedlineTA><NlmUniqueID>0134516</NlmUniqueID><ISSNLinking>0034-9356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Rev Esp Anestesiol Reanim. 1996 Oct;43(8):291-3.</RefSource><PMID Version="1">9011900</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000773" MajorTopicYN="Y">Anesthesia, Obstetrical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9229736</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">9011900</PMID><DateCompleted><Year>1997</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0034-9356</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>1996</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim</ISOAbbreviation></Journal><ArticleTitle>[Anesthesia for cesarean section in patients with mitral valve prolapse].</ArticleTitle><Pagination><StartPage>291</StartPage><EndPage>293</EndPage><MedlinePgn>291-3</MedlinePgn></Pagination><Abstract><AbstractText>Mitral valve prolapse is the most frequent cardiac valvulopathy. Given its greater incidence in young women it is a factor which must be taken into account when performing cesarean section. Two patients with mitral valve prolapse in whom a cesarean section was carried out are presented: case 1, a 22-year-old woman, ASA II, 72 kg, with mitral valve prolapse associated with the Wolf-Parkinson-White syndrome and an episode of paroxysmal supraventricular tachycardia. The cesarean section which was indicated because of the absence of fetal progression was performed under epidural anesthesia. Forty-five minutes after regional blockade a hypotensive episode was observed which remitted following the i.v. administration of 6 mg of methoxamine. No other complication was reported. The Apgar score of the neonate at one minute was 7; case 2, a 31 year-old woman, ASA II, 51 kg, diagnosed with mitral valve prolapse with no associated symptomatology. A cesarean section was performed in this patient because of pedal presentation under general anesthesia without complications. The Apgar score of the neonate at one minute was 8. The physiopathology of mitral valve prolapse as well as anesthesia management during cesarean section in this type of valvulopathy is reviewed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruiz-Castro</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor, Hospital Universitario Pr&#xed;ncipe de Asturias, Alcal&#xe1; de Henares, Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Infante</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Palma</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Anestesia para ces&#xe1;rea en pacientes con prolapso de la v&#xe1;lvula mitral.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim</MedlineTA><NlmUniqueID>0134516</NlmUniqueID><ISSNLinking>0034-9356</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>HUQ1KC1YLI</RegistryNumber><NameOfSubstance UI="D008729">Methoxamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y8335394RO</RegistryNumber><NameOfSubstance UI="D002045">Bupivacaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Rev Esp Anestesiol Reanim. 1997 Mar;44(3):128-9.</RefSource><PMID Version="1">9229736</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Rev Esp Anestesiol Reanim. 1997 Apr;44(4):165-6.</RefSource><PMID Version="1">9244950</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="Y">Anesthesia, Epidural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000773" MajorTopicYN="Y">Anesthesia, Obstetrical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002045" MajorTopicYN="N">Bupivacaine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="Y">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008729" MajorTopicYN="N">Methoxamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013617" MajorTopicYN="Y">Tachycardia, Supraventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014927" MajorTopicYN="Y">Wolff-Parkinson-White Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1996</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9011900</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>